Selecting the ideal ultra sensitive platform for your specific bioanalytical study
Prior to launching a new bioanalytical project, consult Chimera’s technology evaluation services for customized immunoassay solutions.
The quality of available antibody reagents is the basis for any immunoassay. However, study specific requirements may lead to bioanalytical challenges beyond the capabilities of standard large molecule sample testing. At Chimera, we have the scientific expertise and technical capabilities to define the optimal platform technology based on your pharmacological requirements.
The quality of available antibody reagents is the basis for any immunoassay.
However, study specific requirements may lead to bioanalytical challenges beyond the capabilities of standard large molecule sample testing.
At Chimera, we have the scientific expertise and technical capabilities to define the optimal platform technology based on your pharmacological requirements.
Your study needs are unique and, thus, require the optimal platform. Take advantage of our technology evaluation services to identify the immunoassay platform most suited to your particular study.
When evaluating platform suitability, our laboratory and/or consultation services consider the following criteria:
♦ Sensitivity requirement
♦ Regulatory requirements (GLP / GCP)
♦ Desired assay range
♦ Sample volume
♦ BudgetTimeline / Throughput
♦ Single or multi analyte testing
♦ Method transferMatrix effects
♦ Availability of validated commercial assay kits (e.g. high sensitive ELISA kits, Quanterix Kits, Imperacer® kits)
Chimera Biotec:
Your GLP-certifed CRO for ultra sensitive & technically demanding immunoassays since 2000
We have the scientific expertise and technical capabilities to facilitate your choice of ideal platform technology based on your pharmacological requirements.
